GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (XBUL:NVV1) » Definitions » Issuance of Debt

Novavax (XBUL:NVV1) Issuance of Debt : лв0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Novavax Issuance of Debt?

Novavax's Issuance of Debt for the three months ended in Dec. 2024 was лв0 Mil.

Novavax's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was лв0 Mil.

Novavax Issuance of Debt Historical Data

The historical data trend for Novavax's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Issuance of Debt Chart

Novavax Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 301.71 - -

Novavax Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novavax Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novavax Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Novavax's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Novavax Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (XBUL:NVV1) » Definitions » Issuance of Debt
Comparable Companies
SNDX AUPH INVA ADPT MDXG IOVA SYRE ARDX VRDN ETNB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NVAX:USA NVAX:Mexico NVV1:Germany NVV1:Germany NVV1:Germany NVV1:Germany NVAX:Austria
Address
700 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Website
https://www.novavax.com
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Novavax Headlines

No Headlines